Capricor Therapeutics
CAPR
CAPR
32 hedge funds and large institutions have $12.5M invested in Capricor Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 30 → 32 (+2)
0.75% more ownership
Funds ownership: 9.63% → 10.39% (+0.75%)
Holders
32
Holding in Top 10
–
Calls
$528K
Puts
$166K
Top Buyers
| 1 | +$375K | |
| 2 | +$319K | |
| 3 | +$147K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$86K |
| 5 |
BlackRock
New York
|
+$81K |
Top Sellers
| 1 | -$354K | |
| 2 | -$71K | |
| 3 | -$22.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$18.7K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$8.73K |